Last reviewed · How we verify

NCT03785041

Preemptive and Postoperative Intra-articualr Injection of Levobupivacaine and Tramadol

Completed NA Last updated 26 December 2018
What this trial tests

NA trial testing Levobupivacaine Hydrochloride 2.5 MG/ML in Pain After Knee Arthroscop in 220 participants. Completed in 30 May 2018.

Timeline
21 December 2016
Primary endpoint
1 December 2017
30 May 2018

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment220
Start date21 December 2016
Primary completion1 December 2017
Estimated completion30 May 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 60, any sex, with Pain After Knee Arthroscop. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison between preemptive and postoperative intraarticular injection of tramadol on pain sensation after arthroscopy

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparative Study between Preemptive and Postoperative Intra-Articular Injection of Levobupivacaine and Tramadol for Control of Postoperative Pain.
    Metry AA, Wahba RM, Nakhla GM, Abdelmalek FA, et al · · 2019 · cited 3× · PMID 31031486 · DOI 10.4103/aer.aer_20_19

Verify or expand the search:

Other trials of Levobupivacaine Hydrochloride 2.5 MG/ML

Trials testing the same drug.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03785041.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing